It is well established that necrotic cell death is a potent inducer of T cell responses (Gallucci et al., 1999; Shi et al., 2000) and RIPK3-dependent necroptosis is especially effective for eliciting anti-tumor immunity [reviewed in (Aaes and Vandenabeele, 2021)]. This evidence concerns the gene RIPK3 and neoplasm.